Annual CFF
-$8.36 M
-$29.14 M-140.20%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual cash flow from financing activities is -$8.36 million, with the most recent change of -$29.14 million (-140.20%) on December 31, 2023.
- During the last 3 years, ATAI annual CFF has fallen by -$121.41 million (-107.39%).
- ATAI annual CFF is now -102.04% below its all-time high of $409.86 million, reached on December 31, 2021.
Performance
ATAI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.89 M
+$4.57 M+1401.23%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly cash flow from financing activities is $4.89 million, with the most recent change of +$4.57 million (+1401.23%) on September 30, 2024.
- Over the past year, ATAI quarterly CFF has increased by +$4.89 million (+100.00%).
- ATAI quarterly CFF is now -98.69% below its all-time high of $373.76 million, reached on June 30, 2021.
Performance
ATAI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$3.24 M
+$4.89 M+60.16%
September 30, 2024
Summary
- As of February 7, 2025, ATAI TTM cash flow from financing activities is -$3.24 million, with the most recent change of +$4.89 million (+60.16%) on September 30, 2024.
- Over the past year, ATAI TTM CFF has dropped by -$2.42 million (-297.18%).
- ATAI TTM CFF is now -100.64% below its all-time high of $504.30 million, reached on June 30, 2021.
Performance
ATAI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ATAI Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -140.2% | +100.0% | -297.2% |
| 3 y3 years | -107.4% | +3607.6% | -100.8% |
| 5 y5 years | +94.2% | +3607.6% | -100.8% |
ATAI Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.0% | at low | -75.3% | +157.8% | -100.8% | +62.1% |
| 5 y | 5-year | -102.0% | at low | -98.7% | +157.8% | -100.6% | +62.1% |
| alltime | all time | -102.0% | +94.2% | -98.7% | +157.8% | -100.6% | +62.1% |
Atai Life Sciences NV Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.89 M(+1401.2%) | -$3.24 M(-60.2%) |
| Jun 2024 | - | $326.00 K(>+9900.0%) | -$8.13 M(-5.0%) |
| Mar 2024 | - | $0.00(-100.0%) | -$8.56 M(+2.5%) |
| Dec 2023 | -$8.36 M(-140.2%) | -$8.46 M(<-9900.0%) | -$8.36 M(+923.9%) |
| Sep 2023 | - | $0.00(-100.0%) | -$816.00 K(-104.3%) |
| Jun 2023 | - | -$100.00 K(-148.5%) | $18.96 M(-9.1%) |
| Mar 2023 | - | $206.00 K(-122.3%) | $20.86 M(+0.4%) |
| Dec 2022 | $20.79 M(-94.9%) | -$922.00 K(-104.7%) | $20.79 M(-11.3%) |
| Sep 2022 | - | $19.78 M(+1002.6%) | $23.43 M(+211.3%) |
| Jun 2022 | - | $1.79 M(+1259.1%) | $7.53 M(-98.0%) |
| Mar 2022 | - | $132.00 K(-92.3%) | $379.50 M(-7.4%) |
| Dec 2021 | $409.86 M(+262.5%) | $1.72 M(-55.6%) | $409.86 M(-16.4%) |
| Sep 2021 | - | $3.88 M(-99.0%) | $490.12 M(-2.8%) |
| Jun 2021 | - | $373.76 M(+1125.5%) | $504.30 M(+277.1%) |
| Mar 2021 | - | $30.50 M(-62.8%) | $133.74 M(+18.3%) |
| Dec 2020 | $113.05 M | $81.98 M(+353.9%) | $113.05 M(+263.8%) |
| Sep 2020 | - | $18.06 M(+463.7%) | $31.07 M(+138.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $3.20 M(-67.3%) | $13.01 M(+32.7%) |
| Mar 2020 | - | $9.81 M | $9.81 M |
| Dec 2019 | $40.39 M(-128.1%) | - | - |
| Dec 2018 | -$143.69 M(+1281.9%) | - | - |
| Dec 2017 | -$10.40 M(-288.3%) | - | - |
| Mar 2017 | $5.52 M(-272.9%) | - | - |
| Mar 2016 | -$3.19 M(-68.9%) | - | - |
| Mar 2015 | -$10.27 M(+8871.6%) | - | - |
| Mar 2014 | -$114.50 K(-97.3%) | - | - |
| Mar 2013 | -$4.22 M(-56.4%) | - | - |
| Mar 2012 | -$9.68 M(<-9900.0%) | - | - |
| Mar 2011 | $0.00(-100.0%) | - | - |
| Mar 2010 | -$977.40 K(-37.0%) | - | - |
| Mar 2009 | -$1.55 M(-103.9%) | - | - |
| Mar 2008 | $40.21 M(+1878.5%) | - | - |
| Mar 2007 | $2.03 M(-137.6%) | - | - |
| Mar 2006 | -$5.41 M | - | - |
FAQ
- What is Atai Life Sciences NV annual cash flow from financing activities?
- What is the all time high annual CFF for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual CFF year-on-year change?
- What is Atai Life Sciences NV quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly CFF year-on-year change?
- What is Atai Life Sciences NV TTM cash flow from financing activities?
- What is the all time high TTM CFF for Atai Life Sciences NV?
- What is Atai Life Sciences NV TTM CFF year-on-year change?
What is Atai Life Sciences NV annual cash flow from financing activities?
The current annual CFF of ATAI is -$8.36 M
What is the all time high annual CFF for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual cash flow from financing activities is $409.86 M
What is Atai Life Sciences NV annual CFF year-on-year change?
Over the past year, ATAI annual cash flow from financing activities has changed by -$29.14 M (-140.20%)
What is Atai Life Sciences NV quarterly cash flow from financing activities?
The current quarterly CFF of ATAI is $4.89 M
What is the all time high quarterly CFF for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly cash flow from financing activities is $373.76 M
What is Atai Life Sciences NV quarterly CFF year-on-year change?
Over the past year, ATAI quarterly cash flow from financing activities has changed by +$4.89 M (+100.00%)
What is Atai Life Sciences NV TTM cash flow from financing activities?
The current TTM CFF of ATAI is -$3.24 M
What is the all time high TTM CFF for Atai Life Sciences NV?
Atai Life Sciences NV all-time high TTM cash flow from financing activities is $504.30 M
What is Atai Life Sciences NV TTM CFF year-on-year change?
Over the past year, ATAI TTM cash flow from financing activities has changed by -$2.42 M (-297.18%)